ECHO - Pericardial disease Flashcards

1
Q

What is the pericardium?

A
  • doulble-layered membrane with visceral and parietal components
    • visceral: serosal monolayer that adheres firmly to the epicardium, reflects over the origin of the great vessels
    • parietal: tough, fibrous layer
  • pericardial space between the two serosal layers contains up to 50 mL of plasma ultrafiltrate (the pericardial fluid)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When do pericardial pressures rise and restraint becomes clinically important?

A

pericardial reserve volume is exceeded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the pericardial reserve volume?

A

equal to the difference between the unstressed pericardial volume and the cardiac volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the clinicopathologic processes involving the pericardium?

A
  • acute pericarditis
    • and complications of pericardial inflammation (which arise when pericardial fluid accumulates)
  • Pericardial scarring and inelasticity / Compressive syndromes
    • tamponade, constrictive pericarditis, effusive-constrictive pericarditis
  • Tumors
    • primary and metastatic (especially)
  • Congenital pericardial lesions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why is Echo evaluation essential in suspected acute pericarditis?

A
  • Helps identify:
    • pericardial effusion (one of the diagnostic criteria for pericarditis)
    • high-risk patient who warrants hospitalization
  • Excludes other etiologies of chest pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is size of the pericardium measured on Echo?

A
  • semi-quantitatively described by the end-diastolic distance of the echo-free space between parietal and visceral pericardium
    • Small ( < 10 mm) or 50-100 mL
    • Moderate ( 10-20 mm) or 100-500 mL
    • Large ( > 20 mm) or > 500 mL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define cardiac tamponade

A

life-threatening condition caused by fluid accumulation in the pericardial sac

  • characterized by:
    • elevation and equalizatin of cardiac diastolic and pericardial pressures
    • reduced CO
    • Pulsus paradoxus
      • exaggerated inspiratory decrease in arterial systolic pressure ( > 10 mmHg)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the key echocardiographic signs of cardiac tamponade (visually)?

A
  • pericardial effusion
  • small cardiac chambers
  • plethoric IVC
  • supportive signs
    • increased pericardial pressure
      • right sided chamber collapse
      • increased ventricular interdepdendence
        • respiratory variation of ventricular dimensions and transvalvular velocities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the Echocardiographic findings of cardiac tamponade?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are common etiologies of pericarditis?

A
  • Idiopathic
  • Infectious (viral, myocobacterial, fungal, purulent)
  • Autoimmune disease (SLE, Rheumatic fever)
  • Acute myocardial infarction (acute, delayed)
  • Postcardiotomy syndrome (cardiac surgery, trauma)
  • Post-radiation therapy
  • Drug-induced (Isoniazid, cyclosporin)
  • Uremia
  • Neoplastic disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the findings

A
  • PW doppler with respirometer recording of mitral inflow - Cardiac tamponade
    • peak velocities are low because of reduced CO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are characteristic findings in routine evaluation for acute pericarditis?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the four EKG stages of acute pericarditis?

A
  • 2 weeks
    • widespread STE and PR depression with reciprocal changes in aVR
  • 1-3 weeks
    • normalization of ST changes
    • generalized T wave flattening
  • 3- several weeks
    • flattened T waves become inverted
  • Weeks-months
    • EKG returns to normal

****less than 50% of patients progress through all four classical stages and evolution of changes may not follow this typical pattern

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is one treatment tat has been shown to reduce the risk of recurrence of acute pericarditis?

A

Colchicine

  • should be given with NSAIDs
  • 0.6mg x 3 months
    • < 70 kg –> daily
    • > 70 kg –> BID
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is one treatment that has been shown to increase the risk of pericarditis recurrence?

A

Corticosteroids

  • not recommended as first-line therapy (class III, level C per ESC guidelines)
  • can be considered if contraindication or failure of aspirin/NSAIDs and colchicine and if infection is excluded or if another indication (class IIa, level C per ESC guidelines)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What trial demonstrated effectiveness of colchicine in acute pericarditis?

A

ICAP - “Investigation on Colchicine for Acute Pericarditis” (2013)

  • Clinical question (n = 280)
    • In patients experiencing their first episode of acute pericarditis, does colchicine reduce the rate of incessant or recurrent pericarditis when compared to placebo?
  • Bottom line
    • In patient experiencing their first episode of acute pericarditis, the addition of colchicine to NSAID or glucocorticoid therapy significantly reduces the rate of incessant or recurrent pericarditis
  • Primary outcome:
    • reduction of incessant or recurrent pericarditis (16.7% vs. 37.5%)
    • higher remission at one week (85.0% vs. 58.3%)
    • fewer hospitalizations (5.0% vs. 14.2%)
17
Q

What is required for a clinical diagnosis of acute pericarditis?

A
  • at least 2 / 4 of the following:
    • Chest pain that is worse with inspiration and when supine
    • EKG: ST-segment elevation and PR depression
    • Pericardial friction rub
    • Pericardial effusion (more than trivial)
18
Q

What are the categories of pericarditis?

A
  • Acute = < 4-6 weeks
  • Incessant = > 4-6 weeks
  • Chronic = > 3 months
  • Recurrent
    • freedom of symptoms for 4-6 weeks with recurrence
19
Q

What is the probability of developing incessant pericarditis or a first recurrence within 18 months?

A

15-30%

20
Q

What are the high risk markers of acute pericarditis?

A
  • Fever > 38 C (100.4 F)
  • Subacute course (without acute onset of chest pain)
  • Hemodynamic compromise
    • ​suggesting cardiac tamponade
  • ​Large pericardial effusion (on Echo)
  • Immunosuppression
  • Anticoagulation therapy
  • Acute trauma
  • Elevated troponin (suggesting myopericarditis)
21
Q

When should treatment be tapered in patients with acute pericarditis?

A
  • resolution of symptoms and
  • biomarkers (CRP) negative

***usually over several weeks

22
Q

To what degree does Colchicine reduce the risk of recurrent pericarditis?

A

50%

  • meta-analysis including 8 randomized trials ~ 1635 patients
23
Q

What is the major side effect of colchicine therapy?

A

GI intolerance

  • 5-10% of patients
  • improved with dose reduction
24
Q

When should corticosteroids be utilized in patients with acute pericarditis?

A
  • failure of 1st line therapy (NSAIDS, colchicine)
  • Alternative indications
    • autoimmune disease
    • contraindication to NSAIDS or colchicine
      • pregnancy, anticoagulant therapy, renal failure
25
Q

What are the recommendations for activity restriction in acute pericarditis?

A
  • Pericarditis
    • Noncompetitive athletes –>
      • resolution of symptoms
      • normal biomarkers
    • Competitive athletes –>
      • at least 3 months followed by reevaluation
      • resolution of symptoms
      • normal biomarkers
  • Myopericarditis
    • at least 6 months followed by reevaluation
    • resolution of symptoms
    • normal biomarkers
26
Q

What is the treatment dosing for NSAIDS in acute pericarditis?

A
  • Ibuprofen 600-800mg TID
  • Aspirin 650-1000mg TID
  • Indomethacin 25-50mg TID

***resolution of symptoms –> taper dose weekly for 2-4 weeks in an attempt to reduce recurrence rate

27
Q

What patients should receive GI prophylaxis in treatment of acute pericarditis?

A
  • History of PUD
  • Age > 65 years
  • Concurrent use of:
    • ASA
    • Anticoagulation
    • Corticosteroids
28
Q

What is the recommended treatment strategy for corticosteroids in acute pericarditis?

Dosing recommendations?

A
  • Treatment failure or recurrence
  • Low dose > High dose
    • 0.2-0.5 mg/kg/day
    • tapered over 3-6 months
29
Q

What patients require advanced treatments pericarditis?

A
  • Refractory to standard therapy
  • Steroid dependent patients
  • Colchicine-refractory patients
30
Q

What are the advanced treatment options for steroid-dependent and colchicine refractory pericarditis?

A
  • Azathioprine
  • Human immunoglobulins
  • Anakinra
  • Pericardectomy
31
Q

Describe the stages of pericarditis with regards to:

  • Imaging
  • Treatment
A